Abstract
Detailed SAR examination and DIStance COmparison (DISCO) computation were used for identification and superposition of common structural features of 2,3-benzodiazepines with high affinity to an allosteric AMPA binding site. Two similar 4-point models were identified; both contained 2 donor sites, a donor atom and a hydrophobic centre. At one of the donor sites a characteristic difference between the two models was observed.
Keywords: non-competitive ampa antagonist,, 2,3-benzodiazepines, pharmacophore model, disco
Letters in Drug Design & Discovery
Title: Advanced Pharmacophore Model of Non-Competitive AMPA Antagonist 2,3-benzodiazepines
Volume: 1 Issue: 3
Author(s): B. Rezessy and S. Solyom
Affiliation:
Keywords: non-competitive ampa antagonist,, 2,3-benzodiazepines, pharmacophore model, disco
Abstract: Detailed SAR examination and DIStance COmparison (DISCO) computation were used for identification and superposition of common structural features of 2,3-benzodiazepines with high affinity to an allosteric AMPA binding site. Two similar 4-point models were identified; both contained 2 donor sites, a donor atom and a hydrophobic centre. At one of the donor sites a characteristic difference between the two models was observed.
Export Options
About this article
Cite this article as:
Rezessy B. and Solyom S., Advanced Pharmacophore Model of Non-Competitive AMPA Antagonist 2,3-benzodiazepines, Letters in Drug Design & Discovery 2004; 1 (3) . https://dx.doi.org/10.2174/1570180043398948
DOI https://dx.doi.org/10.2174/1570180043398948 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biochemical and Docking Analysis of Substrate Interactions with Polyisoprenylated Methylated Protein Methyl Esterase
Current Cancer Drug Targets Patient-Tailored Treatments with Anti-EGFR Monoclonal Antibodies in Advanced Colorectal Cancer: KRAS and Beyond
Current Cancer Drug Targets Drugs Made of RNA: Development and Application of Engineered RNAs for Gene Therapy
Mini-Reviews in Medicinal Chemistry Prognostic and Predictive Biomarkers in Colorectal Cancer. From the Preclinical Setting to Clinical Practice
Current Cancer Drug Targets Heterocyclic Secretase Inhibitors for the Treatment of Alzheimer’s Disease: An Overview
Central Nervous System Agents in Medicinal Chemistry Budesonide: Teaching an Old Dog New Tricks for Inflammatory Bowel Disease Treatment
Current Medicinal Chemistry Risk and Protective Effects of the Complexin-2 Gene and Gene-Environment Interactions in Schizophrenia
Recent Advances in DNA & Gene Sequences (Discontinued) Functional Consequences of Locus Coeruleus Degeneration in Alzheimers Disease
Current Alzheimer Research Editorial: Future Directions for Stem Cell Banking and Therapy
Current Stem Cell Research & Therapy Preface (Nicholas D. P. Cosford)
Current Drug Targets - CNS & Neurological Disorders Meet Our Editorial Board Member:
Central Nervous System Agents in Medicinal Chemistry Genomic and Proteomic Approaches Towards an Understanding of Sleep
CNS & Neurological Disorders - Drug Targets Adenosine and ATP Receptors in the Brain
Current Topics in Medicinal Chemistry Metabolomics and Pharmacological Screening of <i>Aspergillus versicolor</i> Isolated from <i>Hyrtios erectus</i> Red Sea Sponge; Egypt
Current Bioactive Compounds Pathogenesis and Treatment of Secondary Hyperparathyroidism in Dialysis Patients: The Role of Paricalcitol
Current Vascular Pharmacology The Neuroimmunoendocrine Network in the Complex Host-Parasite Relationship During Murine Cysticercosis
Current Topics in Medicinal Chemistry A Critical Evaluation of Adenosine A2A Receptors as Potentially “Druggable” Targets in Huntingtons Disease
Current Pharmaceutical Design Metabotropic Glutamate Receptors 7 within the Nucleus Accumbens are Involved in Relief Learning in Rats
Current Neuropharmacology Prospective Teratology of Retinoic Acid Metabolic Blocking Agents (RAMBAs) and Loss of CYP26 Activity
Current Pharmaceutical Design Update on the Treatment of Pediatric Obsessive-Compulsive Disorder
Current Psychiatry Reviews